Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
Combination of SGLT2i and GLP-1RA achieved significantly better cardiometabolic outcomes compared with SGLT2i alone; this supports the hypothesis that the cardioprotective benefits of GLP-1RA and SGLT2i may be additive.
Authors
- Nathorn Chaiyakunapruk (ORCID: https://orcid.org/0000-0003-4572-8794)
- Alice Cheng (ORCID: https://orcid.org/0000-0003-2729-606X)
- Lin Xie (ORCID: https://orcid.org/0000-0002-8850-6764)
- Xi Tan (ORCID: https://orcid.org/0000-0002-2511-9767)
- Mico Guevarra (ORCID: https://orcid.org/0009-0001-9381-4411)
- Yuanjie Liang (ORCID: https://orcid.org/0000-0003-4566-0865)
Institutions
- University of Utah (US)
- VA Salt Lake City Healthcare System (US)
- Novo Nordisk (United States) (US)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1186/s12933-025-02737-1
- Citations
- 18
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 23.31
Funders
- Novo Nordisk